The invention provides a non-coding
RNA combination and application thereof in mouse
totipotent stem cell induction, and relates to the technical field of
biology. The invention provides a non-coding
RNA combination for inducing totipotency of mouse embryonic stem cells. The non-coding
RNA combination comprises an
enhancer RNA with a sequence as shown in SEQ ID NO: 1, an
enhancer RNA with a sequence as shown in SEQ ID NO: 2 and a long-chain non-coding RNA with a sequence as shown in SEQ ID NO: 3. According to the invention, the
CRISPR inhibition
system is used for synergistically inhibiting the expression of the specific endogenous non-coding RNA combination for the first time, and the mouse embryonic stem cells can be efficiently promoted to be converted into 2C-like cells. Exogenous
transcription factor integration is not needed, so that the
safety risk of a
genome is avoided; precise targeting is realized through sgRNA, and the defect of non-specific off-target of chemical small molecules is overcome; a remarkable synergistic effect is generated, and the induction efficiency of 2C-like cells can be remarkably improved to about 9.09%. The invention provides a
safer, more efficient and controllable new strategy for
stem cell fate
reprogramming and early development research.